We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App

Customizable AI Tool Helps Pathologists Identify Diseased Cells

By LabMedica International staff writers
Posted on 26 Jun 2024
Print article
Image: Green boxes highlight plasma cells — an indicator of infection — in a sample of the tissue lining the uterus (Photo courtesy of Zou lab and Montine lab)
Image: Green boxes highlight plasma cells — an indicator of infection — in a sample of the tissue lining the uterus (Photo courtesy of Zou lab and Montine lab)

Pathologists are tasked with examining body fluids or tissues to diagnose diseases, a process that involves distinguishing rare disease-indicating cells from thousands of normal cells under a microscope. This skill requires extensive training. Artificial intelligence (AI) can assist by learning to differentiate between healthy and diseased cells from digital pathology images. However, traditional AI tools, once trained, lack flexibility. They are designed for specific tasks, such as identifying cancer cells in one organ but not another, and might not align perfectly with a pathologist's specific needs in different scenarios. Now, a collaborative team of computer scientists and physicians has developed a new AI tool that not only identifies diseased cells but also adapts to a pathologist’s requirements.

Developed at Stanford Medicine (Stanford, CA, USA), the tool, named nuclei.io, functions like a human assistant that evolves with feedback. Starting with the basic function of recognizing different cell types by their nuclei, which house genetic material, the tool is designed to improve through interaction. Within an hour of use, nuclei.io can learn to identify the specific cells of interest to a pathologist, enhancing both the speed and accuracy of their work. During its initial trials at Stanford Medicine, the tool demonstrated its ability to speed up and enhance the diagnostic processes, reducing the time and increasing diagnostic accuracy.

In practical tests, where Stanford pathologists used the tool for tasks such as identifying immune cells in uterine biopsies for endometritis or detecting colon cancer cells in lymph nodes, nuclei.io reduced diagnostic times significantly—from 209 seconds to 79 seconds. The AI assistance made the pathologists 62% faster and 72% more accurate in their diagnoses. It is important to note that nuclei.io does not aim to replace the pathologist but rather guide them more efficiently to areas requiring detailed examination. This is part of a broader aim to ensure patients receive rapid and accurate diagnoses. Stanford Medicine pathologists are continuing to evaluate the tool’s effectiveness on a range of diseased cells, showcasing its potential to become a versatile aid in pathology.

“As we face a growing shortage of pathologists, AI tools that work in tandem with doctors have the potential to speed up some of the more tedious, time-consuming parts of our job,” said professor and chair of pathology Thomas Montine, MD, PhD. “One of the strengths of nuclei.io is that it is agnostic to application. This can be a powerful tool for interpreting any biopsy where we are trying to differentiate healthy and malignant cells. That’s not true of any other major AI tool being used in pathology right now.”

Related Links:
Stanford Medicine

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article


Clinical Chemistry

view channel
Image: The new DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer (Photo courtesy of Beckman Coulter Diagnostics)

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability

As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.